medline.ch Gynäkologie Mammae

	Attitudes of Breast Cancer Chemotherapy Patients and Nurses Toward Acceptance of AI Psychological Nursing: A Qualitative Study. J Multidiscip Healthc Chu T, Chen X, Zhang Q, Zhou H, Chen L, Jiang K. PMID: 41859537 [PubMed]
	The Role of 3-dimensional Imaging and Telemedicine in Breast Augmentation Consultations: A Prospective Cohort Study of 1153 Cases and a Randomized Controlled Trial in Thailand. Plast Reconstr Surg Glob Open Pruksapong C, Permpool L. PMID: 41859503 [PubMed]
	A Head-to-Head Meta-Analysis of 35,052 Smooth vs Textured Implants in Breast Reconstruction and Augmentation. Aesthet Surg J Open Forum Tanas Y, Tanas S, Tanas J, Cato L, Nguyen P, Wang J, Ghorab H, Swed S, Spiegel A. PMID: 41859205 [PubMed]
	Locoregional recurrence of triple-negative breast cancer with low tumor-infiltrating lymphocytes: a case report. Pan Afr Med J Khadiri K, Khadrouf Z, Sadry M, Essalihi A, Bouchra O, Benchekroun MT, Karkouri M. PMID: 41858972 [PubMed - indexed for MEDLINE]
	JAK/STAT-mediated regulation of PD-L1 expression in breast cancer: Molecular mechanisms and implications for immunotherapy. iScience Sang H, Zhao X. PMID: 41858895 [PubMed]
	PSYCHOSOCIAL DISTRESS, BODY IMAGE PERCEPTION, AND COPING MECHANISMS AMONG BREAST CANCER PATIENTS: A CROSS-SECTIONAL STUDY AT A TERTIARY HEALTH FACILITY IN SUB-SAHARAN AFRICA. Ann Ib Postgrad Med Sarimiye FO, Oladeji AA. PMID: 41858821 [PubMed]
	Combinatorial Anti-Mitotic Activity of Loratadine/5-Fluorouracil Loaded Zein Tannic Acid Nanoparticles in Breast Cancer Therapy: In silico, in vitro and Cell Studies. Int J Nanomedicine Hamdi M, Al-Tabakha MM, Ali IH, Khalil IA. PMID: 41858579 [PubMed - indexed for MEDLINE]
	Extracellular Vesicles as Emerging Drug Delivery Platforms in Triple-Negative Breast Cancer: A Systematic Review. Int J Nanomedicine Tian J, Chin YZ, Ng MH, Pang KL, Law JX. PMID: 41858569 [PubMed - indexed for MEDLINE]
	Recent Advances in Antibody-Drug Conjugates and Immunotherapy Combinations for Treatment of Triple-Negative Breast Cancer. Breast Cancer (Dove Med Press) Chen H, Lu W, Zhou Y, Guo X, Wu S, Chen Y. PMID: 41858531 [PubMed]
	Prognostic Significance of the CRP-Albumin-Lymphocyte Index (CALLY) in Triple Negative Breast Cancer Patients: A Real-World Retrospective Study. Breast Cancer (Dove Med Press) Liu Y, Zhang F, Guo C, Li Q. PMID: 41858530 [PubMed]
	Emerging Targeted and Multimodal Therapeutic Strategies in Breast Cancer: A Comprehensive Review. Breast Cancer (Dove Med Press) Wu W, He Y, Zhang C. PMID: 41858526 [PubMed]
	Evaluation of the accuracy of cone-beam CT-based dose calculation for target volumes and organs at risk in left-sided breast cancer radiotherapy. Front Oncol Hou X, Bai Z, Jin X, Dai E, Jiang Y, Ma J, Li J. PMID: 41858368 [PubMed]
	Pharmacotherapy agents in prevention and treatment of breast cancer-related lymphedema: a systematic scoping review. Front Oncol Lommer C, Schroeder L, Amato C, Dhakal K, Kotian C, Quiroga D, Paskett ED, Fu MR, McAlearney AS, Collins S, King TA, McLaughlin SA, Myers SP. PMID: 41858365 [PubMed]
	A real-world comparison study of the efficacy of dual-target first-line rescue treatment of human epidermal growth factor receptor 2 positive advanced breast cancer: trastuzumab combined with pertuzumab versus trastuzumab combined with pyrotinib. Front Oncol Zhang L, Li C, Song S, Wang F, Ding T, Liu Z, Jin Y, Yu Z. PMID: 41858362 [PubMed]
	Evaluation of Phosphohistone H3 in Assessment of Mitotic Activity in Invasive Breast Carcinoma: A Correlative Study With Ki-67 and Histologic Grade. Int J Surg Pathol Priyadarshini P, Rao R, Gv C, Kini J, Rn M, Nayak R, Ar SR, Hegde S. PMID: 41858124 [PubMed - as supplied by publisher]
	HER2-low and ultralow breast cancer: interobserver challenges and lessons from a consensus study. J Pathol Transl Med Koh J, Cha YJ, Cho EY, Lee A, Koo JS, Park SY, Kim MH, Jeong JH, Gong G. PMID: 41858035 [PubMed - as supplied by publisher]
	Recent advances in application of hydrogel-based nanomaterials in breast cancer: from drug delivery, immunotherapy mechanisms to clinical applications. J Nanobiotechnology Xu Y, Pan D, Yang Q, Huang C, Zhou J, Wang J, Li Q. PMID: 41857574 [PubMed - as supplied by publisher]
	Correlation of BMI With Potential Barriers to Mammographic Screening: Body Image, Pain, and Perceived Risk of Breast Cancer-A Cross-Sectional Study. J Med Imaging Radiat Oncol Dzidzornu E, McCarthy NS, McBride K, Stewart E, Wilkes J, White A, Hickey M, Lee E, Stone J. PMID: 41857489 [PubMed - as supplied by publisher]
	Tyrosine hydroxylase as a therapeutic target: insights from adrenergic nerve and TNBC cell interactions. J Mol Med (Berl) Luo Y, Han Y, Nie H, Feng M, Wei C, Ma X, Li K, Zhang Z, Wang G, Pan W, Li X, Yi L, Wang DY, Zeng XT, Qiao Y, Yan Y, Lin Y. PMID: 41857421 [PubMed - indexed for MEDLINE]
	Innovative Nanocarriers of Sorafenib in the Optimisation of Therapeutic Outcome: Challenges and Applications in Breast Cancer. AAPS PharmSciTech Chaurawal N, Estrada AR, Pors K, Raza K, Wahajuddin M. PMID: 41857404 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 215794

Seite 1 von 10790

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung